Charles Explorer logo
🇬🇧

Spironolactone further significantly reduces albuminuria in patients with type I diabetes with nephropathy treated by ACE inhibitors or angiotensin antagonists

Publication at First Faculty of Medicine |
2005

Abstract

spironolakton, albuminuria, diabetes, nephropathy, inhibitors ACE, antagonists of angiotenzin